Reference
Institute for Clinical and Economic Review (ICER). ICER Publishes Evidence Report on Mavacamten for Hypertrophic Cardiomyopathy. Internet Document : 7 Oct 2021. Available from: URL: https://icer.org/news-insights/press-releases/icer-publishes-evidence-report-on-mavacamten-for-hypertrophic-cardiomyopathy/
Rights and permissions
About this article
Cite this article
ICER report finds evidence for mavacamten "promising but inconclusive" for treating HCM. PharmacoEcon Outcomes News 889, 31 (2021). https://doi.org/10.1007/s40274-021-08119-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08119-1